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Abstract 
Background: Current World Health Organization and national protocols recommend the ‘test and treat’ strategy for 
the management of uncomplicated malaria, to reduce over prescription of artemisinin-based combination treatment 
(ACT). Therefore, adherence to these protocols varies in different sub-Saharan African countries and no information 
is available for Mozambique. This study was conducted with the aim to evaluate the prescription practices of ACT in 
Mozambique.
Methods: Retrospective audit of medical records corresponding to the period between July and December 2011 
was conducted in 22 health units across 11 provinces in Mozambique. Two health units were selected per province 
according to availability of laboratory data (performing microscopy and rapid diagnostics testing-RDT or RDT only) 
and geographic setting (rural versus urban). At each facility, demographic data, laboratory results (blood smear or 
RDT), and prescription of ACT were all collected from the existing records.
Results: Between July and December 2011, a total of 61,730 cases were tested for malaria, of which 42.7 % 
(26,369/61,730) were positive. A total of 35.361 patients were malaria negative, and ACT was prescribed to 72.0 % 
(25.448/35.361) of them. Prescription of ACT to malaria negative patients was higher in the central region of the coun-
try as compared to the northern and southern (81.1 % in the central region versus 72.4 and 63.7 % in the northern 
and southern, respectively, p = 0.000) and in urban settings (88.7 % in rural versus 58.0 % in urban settings, p = 0.000). 
Stock out of RDT was observed in six (27.3 %) of the health facilities. When no RDT was available, patients were empiri-
cally treated with ACT.
Conclusion: Findings from this study demonstrate that health care worker’s adherence to the new guidelines for 
malaria treatment is poor in Mozambique and prescription of ACT to malaria negative patients remains very high. 
Enhanced training and supervision activities, community education and external quality assurance might lead to 
significant improvements in the clinician’s adherence to the new guideline for malaria treatment in Mozambique.
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Background
Accurate and timely diagnosis and treatment of malaria 
are critical for proper management of the disease and 
other treatable febrile illness. Presumptive diagnosis and 
treatment of malaria, with no reliance on laboratory con-
firmation, was for a long time the common practice in 
sub-Saharan Africa, including Mozambique [1–3]. While 
ineffective, this leads to over-diagnosis of malaria, over-
treatment with anti-malarials, rapid emergence of drug-
resistant strains and increased mortality among febrile 
patients because the true aetiology remains untreated 
[4–6].
In 2010, the World Health Organization (WHO) 
changed the recommendation for the management of 
uncomplicated malaria from presumptive diagnosis to 
the ‘test and treat’ strategy. As per this guidance, pre-
scription of artemisinin-based combination treatment 
(ACT) should be entirely based on laboratory confirma-
tion, either by microscopy or rapid diagnostic test (RDT), 
where this is available [7]. Most African countries, includ-
ing Mozambique, adopted this recommendation and are 
rapidly scaling up RDT to areas where microscopy is not 
available [8]. Implementation of this recommendation, 
will not only avoid unnecessary prescription of ACT to 
non-malaria cases, but will also improve the management 
of non-malaria febrile illnesses and will delay the occur-
rence of drug-resistance strains [9]. Despite the rapid 
expansion of microscopy and widespread availability of 
malaria RDT, adherence to the guidelines for malaria 
treatment is still a challenge in sub-Saharan Africa, where 
administration of ACT to malaria negative patients is still 
high [10–12]. For instance, a recent study conducted in 
Tanzania, found that up to 90  % of anti-malarial drugs 
were prescribed to patients with negative malaria results 
[13]. Zurovac et al. [14] investigated the financial aspects 
of malaria management and found that adherence to the 
guidelines for malaria treatment might save up to 50 % of 
the costs of malaria programmes in sub-Saharan Africa. 
Poor adherence to the guidelines for malaria treatment 
in sub-Saharan Africa has been attributed to insufficient 
training, lack of supervision, socio-cultural aspects and 
lack of trust in the laboratory systems [15, 16]. To data, 
no study has been conducted to investigate the magni-
tude of this problem in Mozambique.
Although health care workers’ adherence to the new 
malaria guidelines has been extensively investigated in 
sub-Saharan Africa, data from different countries has not 
shown a consistent pattern. While significant improve-
ment in the management of malaria was achieved in 
several countries [9, 17, 18], poor adherence to the guide-
lines for malaria was observed in others [10, 19].
This debate has been renewed in the light of the 
recent decline in malaria transmission in several parts of 
sub-Saharan Africa [20–23]. It is conceivable that reduc-
tion of malaria attributable fever, may increases over-pre-
scription of ACT. With regards to Mozambique, previous 
reports demonstrate that malaria prevalence is in decline, 
given national efforts to control the disease [20, 24, 25], 
and also because of the implementation of the Lubombo 
Spatial Development Initiative and Roll Back Malaria 
activities [25–28].
Despite these gains, no study has yet been conducted 
in Mozambique to investigate the clinician’s adherence to 
the new malaria management protocols. This study was 
conducted to assess the prescription practices among 
health care workers in 22 health facilities in Mozam-
bique. Results of this study will guide the National 
Malaria Control Programme (NMCP) in Mozambique to 
improve malaria case management in the country.
Methods
Study area and design
Retrospective data from July to December 2011 was col-
lected in 22 health facilities throughout the Mozambique’s 
11 provinces. In each province, one district was selected 
from which two health facilities were then selected 
(Fig. 1). Districts and health facilities were selected based 
on the following criteria: (i) accessibility: only districts 
that were accessible by road were selected, (ii) geographi-
cal localization: two health facilities were selected in each 
district, one situated in an urban area and another situ-
ated in a rural area, and (iii) availability of laboratory facil-
ities: of the two health facilities selected per district, one 
had laboratory facility (performing both microscopy and 
RDT) and another did not (performing only RDT).
Mozambique is situated on the southeast coast of 
Africa, with a total area of 801,590 square km and over 
2500  km of coastline. The climate is typically tropical 
with two distinct seasons, the rain season from Octo-
ber to March and the dry season from April to Septem-
ber. The relative humidity is high and ranges between 70 
and 80 %. The average annual precipitation is estimated 
to be 600 mm, and varies between 500 and 900 mm. The 
total population of the country is estimated to be 27 mil-
lion, of which approximately 70  % lives in rural areas. 
Smallholder agriculture and fishing represents the main 
source of income [29, 30]. The country is administratively 
divided into three regions (north, center and south), has 
11 provinces and 128 districts. Malaria is holoendemic 
in Mozambique, accounting for an estimated 48 % of all 
outpatient visits and nearly 63 % of all paediatric admis-
sions. It is also estimated that malaria accounts for 26 % 
of total mortality in the country [31]. Mozambique is 
highly vulnerable to natural disasters such as droughts, 
cyclones and floods that often contribute to increased 
transmission of malaria.
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Ethics statement
This study was approved by the Institutional Bioethics 
Committee (ref#: 009.1/CIBS-INS/2012) prior to study 
initiation.
Data collection
Experienced health workers from the Provincial Health 
Directorates reviewed the medical records and col-
lected data using a standardized questionnaire. At each 
health facility, the laboratory results were collected from 
the laboratory logbook. Prescription information and 
information on RDT and ACT stock out were obtained 
from the pharmacy logbook. Prior to study initiation, 
each data abstractor received a comprehensive training 
on how to collect each information properly. The study 
researchers were responsible for the quality control of the 
questionnaires.
Data analysis
Data were entered into a database developed using Epi 
info v 3.5.4 (2008). Each questionnaire was entered in 
duplicate and data matching was performed to iden-
tify errors during data entry. Duration of RDT and ACT 
stock out was dichotomized into “partial stock out” and 
“total stock out,” where stock out occurring for less than 
30 days in a 1 month period was defined as partial, while 
stock out occurring during the entire month was defined 
as total. Analysis was performed using SPSS statistical 
package, version 17 (IBM Corp., Armonk, NY, USA), 
to calculate the frequencies, proportions and bi-variate 
analysis.
Results
General characteristics of the study sample
Between July and December 2011, a total of 61,730 
patients were tested for malaria across 22 health facili-
ties. Of these, 26,369 (42.7  %) were positive. Table  1 
shows that the proportion of patients with positive 
malaria results was higher in health units without labora-
tory facilities (59.4  %; 4650/7826) as compared to those 
with laboratory facilities (40.3 %; 21,719/53,904), slightly 
higher in health facilities located in the northern region 
(54.1  %; 8535/15,783) as compared to those situated in 
the central (37.9  %; 8021/21,172) and southern (39.6  %, 
9813/24,775) region of the country, and higher in health 
facilities located in rural settings (49.8 %; 15,891/31,896) 
as compared to those situated in urban settings (35.1 %, 
10,478/29,834).
Over‑treatment with ACT among malaria negative patients
Frequency of over-prescription of ACT was investi-
gated by assessing the proportion of malaria negative 
patients treated with ACT. Table  1 shows that 72.0  % 
(25,448/35,361) of patients with negative malaria results 
were treated with ACT. Prescription of ACT to malaria 
negative patients was similar in patients seeking care 
at health facilities with and without laboratory facili-
ties (72.0  %; 23,164/32,185 versus 71.9  %; 2284/3176 in 
health facilities with and without laboratory respectively, 
p = 0.899), but was higher in health facilities located in 
the central region of the country (81.1 %; 10,673/13,151) 
as compared to those in the northern (72.4 %; 5247/7248) 
and southern (63.7 %; 9528/14,962) regions (p = 0.000). 













treated with ACT, n 
(E/C %)
p value
Availability of laboratory at the health facility
 With laboratory 
(microscopy and 
RDT)
53.904 21.719 (40.3) 32.185 44.883 23.164 (72.0) 0.899
 Without laboratory 
(RDT)
7.826 4.650 (59.4) 3.176 6.934 2.284 (71.9)
Geographical region
 North 15.783 8.535 (54.1) 7248 13.782 5.247 (72.4) 0.000
 Center 21.172 8.021 (37.9) 13151 18.694 10.673 (81.1)
 South 24.775 9.813 (39.6) 14.962 19.341 9.528 (63.7)
Location of health facility
 Urban 29.834 10.478 (35.1) 19.356 21.703 11.225 (58.0) 0.000
 Rural 31.896 15.891 (49.8) 16.005 30.114 14.223 (88.7)
 Total 61.730 26.369 (42.7) 35.361 51.817 25.448 (72.0)
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Prescription of ACT to malaria negative patients was also 
higher in urban areas (88.7  %; 14,223/16,005) as com-
pared to rural areas, (58.0 %; 11,225/19,356), respectively 
(p = 0.000) (Fig. 1).
Figure  2a, b show that the lowest frequency of ACT 
prescription to malaria negative patients was observed 
during July and August, with a slight increase from Sep-
tember to December.
Profile of stock‑out of RDT and its impact on prescription 
of ACT
Stock-out of RDT and its impact on ACT prescription 
was also assessed. During the period under investigation, 
a total of six (27.3 %) health facilities registered stock-out 
of RDT. Table 2 shows that the duration of stock-out in 
these health facilities varied from <1 month up to three 
consecutive months.
Table 2 also shows that in health facilities with partial 
stock-out, the number of patients who received ACT 
was much higher than the number of patients who were 
tested for malaria. Of remark, during the periods of total 
stock-out of RDT, no patient was tested for malaria and 
all suspected cases were empirically treated with ACT.
Profile of stock‑out of ACT and its impact on prescription 
of ACT
Table 2 indicates that stock-out of ACT was reported in 
three (13.6 %), out of 22 health facilities sampled. Table 3 
shows that during periods of partial stock-out of ACT, 
the number of patients who received ACT was lower 
than those who were malaria positive. Of note, during 
periods of total stock-out of ACT, none of the patients 
with malaria positive results received ACT and all of 
them were referred to the nearby health facility to receive 
their anti-malarial treatment.
Discussion
In 2011 Mozambique adopted the new WHO guidelines 
for the management of malaria and stipulated that pre-
scription of ACT for the treatment of uncomplicated 
malaria should be guided and based on laboratory con-
firmation using either microscopy or RDT as opposed to 
presumptive diagnosis and treatment. Health care work-
ers’ adherence to this guideline has never been assessed 
in Mozambique and data from other sub-Saharan coun-
tries are conflicting [9, 10, 18, 19], suggesting that pre-
scription practices for ACT is country specific.
This is the first study investigating health care work-
ers’ adherence to these guideline in Mozambique. 
Results of this study showed that ACT was prescribed 
to 72.0  % (25,448/35,361) of patients with negative 
malaria results. This suggests that despite the availabil-
ity of laboratory testing using either RDT or microscopy 
in Mozambique, health care workers’ adherence to the 
guideline for malaria treatment is poor and the disease is 
largely treated presumptively. Similar results were found 
in other sub-Saharan Africa countries where malaria is 
endemic [10, 13, 32]. A study conducted in Zambia dem-
onstrated that 84 % of patients who received ACT were 
malaria negative [16] and another study conducted in 
Malawi found that ACT was prescribed to 58 % of febrile 
patients with negative RDT results [10]. As previously 
mentioned, over-treatment with ACT is expensive, and 
leads to unnecessary wastage of drugs, increased morbi-
mortality associated with misdiagnosis of treatable non-
malaria febrile illnesses and rapid acquisition of drug 
resistance [6]. Adherence to the new protocol for malaria 
management is considered a cost effective intervention, 
as a study conducted in Kenya demonstrated that correct 
management of malaria can save up to 60 % of costs asso-
ciated with malaria treatment [14].
Concern on the over treatment of ACT has recently 
increased, because the burden of malaria is declining in 
many sub-Saharan Africa countries, including in Mozam-
bique [20, 21, 25], and as a consequence, the likelihood of 
treating malaria negative with ACT may increase.
While the results of this study suggest that RDT results 
are underutilized in Mozambique, the underlying reasons 
for poor uptake and utilization of malaria RDTs results 
were not addressed in this study and merit further inves-
tigation. However, socio-behavioural studies from other 
countries demonstrate that patients’ expectations to 
receive anti-malarial treatment along with a lack of skills 
to deal with patients’ expectations in the presence of neg-
ative result places a strong psychological pressure on cli-
nicians [33–35]. This suggests that community education 
on management of febrile illness is also critical. Other 
reasons for the overtreatment of ACT described in previ-
ous studies conducted in other sub-Saharan Africa coun-
tries are: (i) clinicians’ resistance to adhere to the new 
guidelines, because presumptive diagnosis was a com-
mon and accepted practice for many years, (ii) lack of 
trust in the national laboratory systems, (iii) fear of false 
negative test results [16, 36], and (iv) lack of epidemio-
logical information on the alternative diagnosis of acute 
fever [6]. Because of this, there is an urgent need of stud-
ies to investigate the aetiology of fever of unknown origin 
in sub-Saharan Africa.
It’s well documented that comprehensive training, 
periodic refresher courses and regular supervision vis-
its leads to improvement of clinicians’ adherence to the 
new guidelines for malaria management. In fact, recent 
studies conducted in Tanzania demonstrated that adher-
ence to new malaria guidelines was enhanced by com-
prehensive training, education and supervision [9, 37]. 
Another study conducted in Ghana found similar results 
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[38]. Implementation of quality control measures is also 
important, and previous studies demonstrated that the 
expansion of external quality control programmes for 
RDT and microscopy improved clinicians’ confidence of 
results [9, 39, 40].
Data from this study showed that stock-out of RDT 
was a common finding and resulted in increase in the 
frequency of presumptive ACT prescription. These find-
ings are similar to those from a study conducted in Benin 
in 2010, which found that stock-out of RDT occurred in 
up to 38.5 % of health facilities and influenced prescrip-
tion of ACT [41]. This suggests that improvement in the 
supply chain for ACT is critical to minimize over-pre-
scription of ACT.
Fig. 1 Geographical distribution of 11 districts and 22 health facilities. Coloured districts represent the selected districts in each province
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In this study, adherence to the new protocol for malaria 
management was lower in the central part of the coun-
try, suggesting that health care workers’ prescription 
practices varies across the country. Over-prescription 
was also slightly higher in rural areas as compared to 
urban areas. This might be due to higher literacy and 
better access to information among clinicians working 
in urban settings, but additional research is needed to 
investigate this.
Of note, the quality of medical records is a limiting fac-
tor when conducting retrospective studies. To minimize 
some of these problems, the followings strategies were 
implemented during this study, (i) comprehensive train-
ing of all staff who were involved in data collection, (ii) 
random selection of questionnaires for quality checks 
and (iii) only recent data, corresponding to the period 
between July and December 2011 were collected, since 
the risk of loosing medical records increases as the stor-
age time increases. Despite these efforts, common errors 
may still have occurred. The Ministry of Health recently 
launched its strategy to improve the quality of routine 
data.
Conclusions
Overall, the findings of this study showed that clinicians’ 
adherence to the new WHO guidelines for malaria man-
agement in Mozambique are poor and varies by regions 
of the country. Stock out of RDT is a strong contribut-
ing factor for the presumptive treatment with ACT. 
This study suggests that the roll out of RDT should be 
Fig. 2 Monthly variation of the frequency of patients tested, con-
firmed and treated for malaria. a Patients tested and confirmed for 
malaria and treated with ACT and b monthly variation in the propor-
tion of patients over-treated with ACT
Table 2 List of health facilities with stock out of RDT, the corresponding period and type of RDT stock out
a Total stock out of RDT = duration of stock out was 30 days (entire month)
b Partial stock out of RDT = duration of stock out was <30 days
Months between July and December  
2011 in which stock out of RDT  
was reported, month
Type of stock  
out of RTD




Health facility with stock out of RDT # 1
July and August Totala 0 268
September and December Partialb 311 971
Health facility with stock out of RDT # 2
 September, October and December Total 0 287
Health facility with stock out of RDT # 3
 December Total 0 80
Health facility with stock out of RDT # 4
 July Total 0 360
Health facility with stock out of RDT # 5
 July Partial 50 210
 August Total 0 210
 September and October Partial 50 210
 November Total 0 210
Health facility with stock out of RDT # 6
 July and August Total 0 283
 September and December Partial 233 386
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accompanied by continuous training, frequent refresh 
courses, regular supervision, community education, 
implementation of quality assurance schemes and 
improvement of supply chain for RDT.
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